HOME >> BIOLOGY >> NEWS
New data reveal pregnancies exposed to accutane despite risk management program

WHITE PLAINS, N.Y., July 31, 2007 Despite a mandatory program designed to prevent pregnant women from being exposed to the anti-acne medication Accutane and similar medications containing isotretinoin (a known teratogen or birth defect-causing agent), 122 pregnancies were exposed during the first year of the program, known as iPledge, a report revealed.

The March of Dimes Foundation said it is evaluating the report and will carefully review any proposed changes to the program following the meeting tomorrow of the FDAs Dermatologic and Ophthalmic Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee.

Its certainly a positive step that FDA and the drug manufacturers have made this information publicly available, so that the iPledge program can be properly evaluated, said Michael Katz, M.D., senior vice president for Research and Global Programs of the March of Dimes. Although no human system will ever be perfect, the goal is to prevent birth defects to the fullest extent possible. No woman should ever take isotretinoin while pregnant and no woman should get pregnant while taking isotretinoin. Too many pregnancies still are being exposed to this drug.

Recently, the FDA said it took steps to close a loophole in the iPledge program by warning women not to buy Accutane, or any generic forms of the drug, over the Internet, to bypass the monitoring program.

Isotretinoin, one of the most potent teratogens, is marketed under several brand names to treat severe acne that does not respond to conventional treatments. More than 1.5 million prescriptions were written annually according to 2001-2002 FDA data.

Isotretinoin is chemically related to vitamin A. Birth defects associated with isotretinoin include mental retardation, brain and heart defects. Birth defects or miscarriages can occur soon after conception, often before a woman realizes she is pregnant.


'"/>

Contact: Elizabeth Lynch
elynch@marchofdimes.como
914-997-4286
March of Dimes Foundation
31-Jul-2007


Page: 1

Related biology news :

1. Study begins to reveal clues to the cause and progression of sepsis
2. Satellite tracking reveals threats to Borneo pygmy elephants
3. New technology reveals seal behavior
4. Universes stringy birth revealed by young Czech scientist in EURYI winning project
5. Discredited Korean embryonic stem cells true origins revealed
6. Innovative research technique reveals another natural wonder in Yellowstone Park
7. Limpets reveal possible fate of cold-blooded Antarctic animals
8. Satellite images reveal link between urban growth and changing rainfall patterns
9. Time-lapse recordings reveal why IVF embryos are more likely to develop into twins
10. Mathematics reveals genetic pattern of tumor growth
11. CU study reveals why starling females cheat

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/27/2020)... ... January 27, 2020 , ... Cytonus Therapeutics Inc. today announced ... entrepreneur, and former senior management consultant at McKinsey & Company who holds three ... investment firm. , “Chris Thorne has exceptional business acumen with a proven ...
(Date:1/23/2020)... ... January 23, 2020 , ... GIOSTAR/HEAMGEN ... from stem cells. The red blood cells are made utilizing a bioreactor ... for transfusion therapy and replaces the need for a human blood donor. ...
(Date:1/22/2020)... (PRWEB) , ... January 21, 2020 , ... Lifecycle Biotechnologies announces the new ... to each users’ unique needs based on their process requirements and accurately weighed to 0.001 ... Buffers , Salts , Sugars , Carbohydrates , ...
Breaking Biology News(10 mins):
(Date:1/27/2020)... ... January 27, 2020 , ... ... secured financing from strategic investors led by Halma plc , a FTSE ... Sonion, TDF Ventures, GII LLC, and WSJ Joshua Fund. A representative from Halma ...
(Date:1/24/2020)... ... January 24, 2020 , ... Sierra Instruments, global leader ... and controllers ideal for BioPharm OEMS. Sierra also announces RedyCompact™ ... thermal instruments employ high-precision MEMS (Micro-Electro Mechanical Systems) technology utilizing an advanced, ultra-stable ...
(Date:1/22/2020)... ... January 21, 2020 , ... Microbial Discovery Group LLC (MDG) ... Industrial and Institutional (I&I) Account Manager. Darrell will focus on servicing MDG’s partners ... over 30 years of sales experience working across multiple different market sectors such ...
(Date:1/10/2020)... ... January 09, 2020 , ... A new report from ... vendor qualification process, a critical element of clinical trial set up and execution. ... vendor qualification process creates delays in initiation in 7% of clinical trials for ...
Breaking Biology Technology:
Cached News: